MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
This Quarter Return
-3.69%
1 Year Return
+6.34%
3 Year Return
+31.77%
5 Year Return
–
10 Year Return
–
AUM
$200M
AUM Growth
+$200M
(+7.3%)
Cap. Flow
+$23.5M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
59.56%
Holding
77
New
11
Increased
21
Reduced
21
Closed
5
Top Buys
| 1 |
Alcoa
AA
|
$15.8M |
| 2 |
AngloGold Ashanti
AU
|
$9.5M |
| 3 |
Invesco QQQ Trust
QQQ
|
$7.17M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$6.02M |
| 5 |
Pan American Silver
PAAS
|
$4.1M |
Top Sells
| 1 |
UBS Group
UBS
|
$5.91M |
| 2 |
Alibaba
BABA
|
$5.42M |
| 3 |
Hecla Mining
HL
|
$4.83M |
| 4 |
CELL
PhenomeX Inc. Common Stock
CELL
|
$3.38M |
| 5 |
LendingTree
TREE
|
$3.36M |
Sector Composition
| 1 | Materials | 27.25% |
| 2 | Healthcare | 26.81% |
| 3 | Technology | 11.14% |
| 4 | Financials | 5.35% |
| 5 | Consumer Discretionary | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
VanEck Gold Miners ETF
GDX
$19B
| $20.2M | 5.99% |
750,000
| – | – |
|
|
2
Alcoa
AA
$8.33B
| $17M | 5.04% |
585,000
+545,000
| +1,363% | +$15.8M |
|
|
3
Teva Pharmaceuticals
TEVA
$21.1B
| $15.6M | 4.61% |
1,525,000
+590,587
| +63% | +$6.02M |
|
4
Viatris
VTRS
$12.3B
| $15.3M | 4.53% |
1,550,051
-24,949
| -2% | -$246K |
|
5
Zoom
ZM
$24.4B
| $11.1M | 3.29% |
158,448
-16,552
| -9% | -$1.16M |
|
|
6
AngloGold Ashanti
AU
$28.6B
| $9.5M | 2.82% |
+601,432
| New | +$9.5M |
|
|
7
Pan American Silver
PAAS
$12.3B
| $9.05M | 2.68% |
625,000
+283,315
| +83% | +$4.1M |
|
8
PayPal
PYPL
$67.1B
| $7.39M | 2.19% |
126,400
+31,400
| +33% | +$1.84M |
|
|
9
Invesco QQQ Trust
QQQ
$364B
| $7.17M | 2.13% |
+20,000
| New | +$7.17M |
|
10
StoneCo
STNE
$4.41B
| $6.74M | 2% |
632,136
-82,864
| -12% | -$884K |
|
|
11
Alibaba
BABA
$322B
| $5.07M | 1.5% |
58,500
-62,500
| -52% | -$5.42M |
|
12
Agnico Eagle Mines
AEM
$72.4B
| $4.51M | 1.34% |
99,224
-22,496
| -18% | -$1.02M |
|
|
CMRX
13
DELISTED
Chimerix, Inc.
CMRX
| $4.2M | 1.25% |
4,377,674
| – | – |
|
14
Fate Therapeutics
FATE
$120M
| $3.92M | 1.16% |
1,847,944
+842,718
| +84% | +$1.79M |
|
15
DNOW Inc
DNOW
$1.68B
| $3.64M | 1.08% |
306,756
+76,424
| +33% | +$907K |
|
16
Alamos Gold
AGI
$12.8B
| $3.56M | 1.05% |
315,000
+19,164
| +6% | +$216K |
|
17
Amplify Junior Silver Miners ETF
SILJ
$1.98B
| $3.18M | 0.94% |
375,000
+300,000
| +400% | +$2.54M |
|
|
18
UBS Group
UBS
$128B
| $3.06M | 0.91% |
123,647
-238,803
| -66% | -$5.91M |
|
19
Nektar Therapeutics
NKTR
$568M
| $2.86M | 0.85% |
4,809,601
-4,451,116
| -48% | -$2.65M |
|
20
Newmont
NEM
$81.7B
| $2.85M | 0.84% |
+77,000
| New | +$2.85M |
|
21
Dollar General
DG
$23.9B
| $2.65M | 0.78% |
+25,000
| New | +$2.65M |
|
22
Zymeworks
ZYME
$1.12B
| $2.64M | 0.78% |
416,275
+6,755
| +2% | +$42.8K |
|
23
AdvisorShares Pure US Cannabis ETF
MSOS
$986M
| $2.54M | 0.75% |
320,447
-44,553
| -12% | -$354K |
|
24
Oric Pharmaceuticals
ORIC
$994M
| $2.33M | 0.69% |
384,793
+6,571
| +2% | +$39.8K |
|
25
B2Gold
BTG
$5.46B
| $2.24M | 0.66% |
775,000
+507,635
| +190% | +$1.47M |
|